|
|
||||||||
Nephrologisches Labor, Medizinische Klinik IV, Universität Erlangen-Nürnberg, 91054 Erlangen, Germany
| |
ABSTRACT |
|---|
|
|
|---|
Cytokine-induced nitric oxide (NO) is produced
on glomerular inflammation. Glomerular injury and thrombocyte
aggregation result in the release of nucleotides, which may regulate
induced NO synthesis in cultured rat mesangial cells (MCs). ATP
(10
3 M) inhibited 24-h
nitrite production induced by lipopolysaccharide (LPS, 10 µg/ml)/interferon-
(IFN-
, 100 U/ml) by 48.2 ± 6.3%, as
well as induction of inducible NOS (iNOS) protein and mRNA. Also,
coincubation with either
10
4 M of UTP, ATP, or
ATP
S inhibited LPS/IFN-
-induced nitrite production by 29.9 ± 5.8, 36.4 ± 4.3, and 50.3 ± 6.5%, respectively, indicating involvement of purinergic P2Y2 receptors. Correspondingly, cultured MCs
expressed P2Y2 receptor mRNA. Agonists for other purinergic receptors
[
,
-methylene-ATP,
3'-O-(4-benzoyl)-benzoyl-ATP,
2-methylthio-ATP, ADP, UDP, adenosine] were ineffective.
Treatment with the protein kinase C (PKC) activator phorbol
12-myristate 13-acetate (PMA, 10
8 M) reproduced the
inhibitory effect of ATP on iNOS protein expression and nitrite
inhibition (by 46.6 ± 10.4%). The effect of ATP or PMA was
reversed by the PKC inhibitors Ro-31-8220
(10
8 M) and
1-(5-isoquinolinylsulfonyl)-2-methylpiperazine
(10
5 M),
indicating that suppression of iNOS is mediated via activation of PKC
through stimulated P2Y2 receptors. In conclusion, the release of purine
mediators may play a critical role for iNOS expression and synthesis of
NO during glomerular inflammatory disorders.
purinergic receptors; inducible nitric oxide synthesis; glomerular inflammation; protein kinase C
| |
INTRODUCTION |
|---|
|
|
|---|
THE GLOMERULAR INFLAMMATORY response is characterized by a number of phenotypical changes, such as proliferation of mesangial cells (MCs) and increased deposition of extracellular matrix proteins in the mesangial space (1, 22). In addition, an increased synthesis of nitric oxide (NO) resulting from cytokine-mediated stimulation of the inducible NO synthase (iNOS) expressed by resident glomerular and inflammatory cells may contribute as a proinflammatory mechanism to the pathogenesis of glomerulonephritis. In cultured glomerular MCs, the expression of iNOS activity and mRNA on stimulation with cytokines or lipopolysaccharide (LPS) has been demonstrated by several investigators (27, 28, 35, 41). This enzyme, once expressed, releases large amounts of NO from the conversion of L-arginine plus oxygen to L-citrulline (reviewed in Ref. 23). A first report of induced NO synthesis being involved in glomerulonephritis came from a rat model of accelerated nephrotoxic nephritis (6). Molecular evidence for a participation of iNOS was provided with the identification of increased and activated iNOS enzyme in different rat models of glomerulonephritis (12, 21, 30). In certain models of autoimmune disease, inhibition of NO synthesis improved the accompanied glomerulonephritis (47). This indicated the potential proinflammatory role of induced NO synthesis.
With the destruction of resident or invading cells and with the activation of thrombocytes and their aggregation, all of which accompany glomerular inflammatory injury, large amounts of mononucleotides such as ATP and UTP are released. The nucleotides bind to cell surface receptors, which are designated as purinergic P2 receptors and expressed by many cell types. Several P2 receptors (5) have recently been cloned and can be divided into two groups: 1) P2X receptors are ATP-regulated ion channels, and 2) P2Y receptors are G protein-coupled heptahelical receptors. Each group is constituted by seven members, designated P2X1-P2X7 and P2Y1-P2Y7, respectively. The expression of P2Y2 receptors in MCs has been postulated in previous studies by functional criteria, since both ATP and UTP led to stimulation of phosphatidylinositol-specific phospholipase C (33, 40), increase in intracellular calcium (32), inhibition of cAMP accumulation (37), and activation of mitogen-activated protein kinases (18). Furthermore, it has been shown that extracellular ATP induces mitogenesis (18, 19, 39, 40) and contraction (32) in cultured rat MCs.
The aim of this study was to examine whether extracellular
mononucleotides may regulate iNOS expression and activity in cultured rat MCs and which signal transduction pathways are involved in this
potential regulatory pathway. Our results verify the presence of the
purinergic P2Y2 receptor in cultured MCs by demonstrating its mRNA
expression. Extracellular ATP and UTP strongly inhibited LPS/IFN-
-induced iNOS mRNA, protein, and activity by binding to
purinergic P2Y2 receptors and subsequently activating protein kinase C
(PKC). The release of nucleotides into the extracellular space may
therefore critically regulate the generation of NO during the
glomerular inflammatory response.
| |
MATERIAL AND METHODS |
|---|
|
|
|---|
Material. Dulbecco's modified
Eagle's medium (DMEM),
L-glutamate, insulin,
penicillin, streptomycin, LPS (Escherichia
coli serotype 026:B6), interferon-
(IFN-
),
NG-monomethyl-L-arginine
(L-NMMA), ATP, adenosine
5'-O-(3-thiotriphosphate) (ATP
S), ADP, AMP, adenosine, UTP, UDP, UMP, uridine,
,
-methylene-ATP (APCPP),
3'-O-(4'-benzoyl)-benzoyl-ATP
(BzATP), 2'-methylthio-ATP (2-MeS-ATP), phorbol
12-myristate 13-acetate (PMA), and
1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H-7) were all purchased
from Sigma (Deisenhofen, Germany). Ro-31-8220 was purchased from
Biomol, and fetal calf serum (FCS) was from Boehringer (Mannheim,
Germany). Tissue culture plastic was from Falcon (Becton-Dickinson,
Heidelberg, Germany).
Cell culture and isolation of MCs. For
preparation and culture of glomerular MCs from male Sprague-Dawley
rats, standard techniques were used, as described previously (20, 25,
28). Briefly, the kidneys were excised, and the cortex was separated
from the medulla and homogenized using razor blades. Glomeruli were
isolated from the homogenate by sequential sieving and collected on a
75-µm sieve. After treatment with 500 U/ml collagenase (type IV,
Sigma) in phosphate-buffered saline for 30 min, the glomerular remnants consisting predominantly of endothelial cells and MCs were seeded in
tissue flasks (30,000 glomeruli/flask) containing DMEM supplemented with 20% FCS, 5 µg/ml bovine insulin, 100 U/ml penicillin, and 100 µg/ml streptomycin. After three to four passages using 0.05% trypsin-0.02% EDTA, stable and homogenous cultures of MCs were obtained. The outgrowing cells were characterized as MCs by positive immunocytochemical staining for Thy-1.1 (Serotec; Blackthorn, Bicester,
UK), smooth muscle cell actin, and myosin showing typical MC morphology
(25). MCs were further cultured in DMEM supplemented with 10%
heat-inactivated (56°C for 1 h) FCS, 2 mM glutamate, 5 ng/ml
insulin, 100 U/ml penicillin, and 1 mg/ml streptomycin. Cells were used
for experiments at subconfluence or passaged at confluence with
trypsin-EDTA (0.05%-0.02%, wt/vol). To obtain quiescent cells, MCs
were maintained in medium containing 0.5% FCS for 3 days before
cytokine treatment. MCs were used between passages 15 and 25. To
stimulate iNOS induction, we used LPS (E. coli serotype 026:B6, 10 µg/ml medium) and IFN-
(100 U/ml medium). Subconfluent quiescent MCs were coincubated
according to the experimental conditions with ATP
(10
6-10
3
M), ATP
S
(10
7-10
4
M), ADP, AMP, adenosine, UTP, UDP, UMP, uridine, APCPP, 2-MeS-ATP, BzATP (all at 10
4 M), PMA
(10
8 M), H-7
(10
5 M), and Ro-31-8220
(10
7 M).
Measurement of NO production by detection of nitrite in cell culture supernatants. MCs were grown to subconfluence either in 24-well plates or to accommodate protein or RNA extraction on 60- and 100-mm plastic culture plates. The cells were conditioned in standard culture medium between 24 and 32 h, according to the experimental protocol. The nitrite content was measured using the Griess colorimetric method (13, 28). Briefly, 200 µl of the supernatant as well as control medium supplemented with known NaNO2 concentrations serving as standard were mixed with 50 µl of Griess reagent (25 mM sulfanilamide and 25 mM naphtylethylenediamine) and 25 µl of 6 M HCl and incubated for 30 min in the dark. Optical density was measured at 550 nm with an ELISA reader, and the nitrite content of the conditioned medium was calculated according to the NaNO2 standard curve obtained.
Preparation of radioactive cDNA probes (rat P2Y2, rat
iNOS, and rat GAPDH). A probe for the rat P2Y2 receptor
was provided by Dr. D. Julius (San Francisco, CA) (26). We used two
sets of iNOS probes. First, we chose an EcoR
I/Pst I-cut insertion of the plasmid piNOS B2 (48), a mouse
iNOS cDNA clone. This 611-bp fragment is part of the 5'-coding
region of the iNOS gene. Second, we used an 1,639-bp rat iNOS fragment,
which we gained by homology-based reverse transcription-polymerase
chain reaction (RT-PCR) (40 cycles, annealing temperature 60°C) of
LPS/IFN-
-induced (24 h) cultured rat MCs, using the following
primers (synthesized by Life Technologies): sense,
5'
TGCATGGACCAGTATAAGGCAAGC 3' (position 1877-1900 of M84373); and antisense, 5'
ACCTGCTCCTCGCTCAA 3' (position
3479-3495 of M84373) (added restriction sites are
underlined).
The glyceraldehyde-3'-phosphate dehydrogenase (GAPDH) probe was gained using an homology-based RT-PCR (30 cycles, annealing 50°C) of rat MC cDNA, using the following primers (synthesized by Life Technologies): sense, 5' AATGCATCCTGCACCACCAA 3' (position 469-488 of M17701); and antisense, 5' GTCATTGAGAGCAATGCCAGC 3' (position 919-939 of M17701).
32P labeling was performed for all probes using the random prime labeling kit (Boehringer).
Northern blot hybridization analysis.
Total RNA from rat MCs grown to subconfluence in 100-mm culture dishes
was obtained, as described earlier (7, 28). Twenty micrograms of total RNA were electrophorectically size fractionated under denaturing conditions, using 1% agarose including 1.8% formaldehyde. The separated RNA was capillary transferred by 20× standard sodium citrate (SSC) to nylon membranes (Amersham) and fixed though
ultraviolet crosslinking. Next, the RNA was prehybridized (5×
Denhardt's solution, 5× SSC, 50 mM
Na3PO4,
0.1% SDS, 250 mg herring sperm DNA, 50% formamide) for at least 2 h
at 42°C and then hybridized with the appropriate
32P-labeled cDNA-specific probes (P2Y2 probe, mouse
macrophage iNOS probe followed after stripping by rat vascular smooth
muscle iNOS probe) for 24 h, using the same conditions. The membrane
was washed at 42°C twice for 15 min with 2× SSC, 0.1% SDS,
for 30 min with 0.1× SSC, 0.1% SDS, and exposed to X-ray film
(Kodak XAR-5, supplied by Sigma) at
80°C for at least 24 h.
To rectify for RNA transfer and content, filters were stained with
bromophenol blue (0.04% in 500 mM sodium acetate, pH 5.5) and
rehybridized with a 32P-labeled
rat GAPDH probe.
Purinergic P2Y2 receptor RT-PCR. One microgram of total RNA of quiescent cultured rat MCs was subjected to an RT reaction using oligo(dT)16, according to the protocol of the Perkin-Elmer Cetus GeneAmp RNA PCR kit. Specific primers for the homology-based PCR (30 cycles, annealing at 56°C) produced PCR products, which were size separated on ethidium bromide-stained agarose gels, revealing DNA bands at the expected 380 bp size. Negative controls for the RT and the PCR reagents remained negative. Primer (synthesized by Eurogentec) sequences were as follows: sense, 5' CAGCGTGAGAGGGACCCGAA 3' (positions 521-540); and antisense, 5' TGAGGTCAAGTGATCGGAAG 3' (positions 881-900).
iNOS protein Western blot analysis.
Preparation of MC lysates and immunoblot analysis was performed using
time-matched 60-mm plates of MCs. They were incubated with complete
medium containing 0.5% FCS, medium supplemented with LPS (10 µg/ml
medium)/IFN-
(100 U/ml medium) or medium supplemented additionally
with reagents according to the experimental protocol. After the
incubation period, the medium was removed and assayed for the nitrite
content, as described above. The plates were washed twice with ice-cold
phosphate-buffered saline. Thereafter, 0.5 ml of boiling lysis buffer
solution (1% SDS, 10 mM Tris, pH 7.4) was added to the cells. The cell
lysates were collected in centrifuge tubes after boiling and spinning at 12,000 g for 5 min at 4°C.
Protein contents were determined using the bicinchoninic acid protein
assay reagent (BCA; Pierce, Munich, Germany). The samples (10 µg)
were diluted in electrophoresis sample buffer (250 mM Tris, pH 6.8, 4%
SDS, 10% glycerol, 0.006% bromophenol blue, 2% mercaptoethanol),
boiled for 5 min, quenched on ice, and resolved by electrophoresis
though 0.1% SDS-10% polyacrylamide gels. Proteins were
electrophoretically transferred to nitrocellulose membranes (Amersham,
Braunschweig, Germany), and the transfer efficiency was determined
by staining the membranes with Ponceau S. After destaining in distilled
water, the membranes were quenched in blocking solution [5%
powdered dried low-fat milk in washing solution (10 mM Tris, pH 7.5, 100 mM NaCl, 0.1% Tween 20)] 60 min at room temperature. The
blocking solution was decanted, and membranes were incubated for 60 min
at room temperature with the primary antibody [anti-iNOS, rabbit,
polyclonal (Affiniti, Nottingham, UK), 1:1,000]. Membranes were
washed for 30 min at room temperature with several changes of the
washing solution. The secondary detecting antibody was horseradish
peroxidase-conjugated anti-rabbit IgG (1:2,000; Serva, Heidelberg,
Germany), which was used with the enhanced chemiluminescence protocol
(Amersham).
Statistical analysis. When suitable, means ± SE were determined. To test for statistically significant differences, we used Student's t-test or analysis of variance, if multiple comparisons were made against a single control, whenever applicable. Significance was assigned at P < 0.05.
| |
RESULTS |
|---|
|
|
|---|
ATP and ATP
S inhibited
nitrite accumulation in supernatant from cultured rat
MCs. Treatment of cultured rat MCs with LPS (10 µg/ml
medium)/IFN-
(100 U/ml medium) for 24 h led to a significant induction (P < 0.001) of
nitrite production in these cells [control, 1.2 ± 0.4 µmol/ml medium; LPS/IFN-
induction, 17.6 ± 0.7 µmol/ml medium (100%)], which was inhibited by the addition of
the NOS inhibitor L-NMMA
(10
4 M) by 87.3 ± 4.9%
(P < 0.001). This indicated that
nitrite accumulation in our experimental system was due to NOS activity
(43). When ATP was given together with LPS/IFN-
dose dependently the
nitrite production was reduced, significantly by 48.2 ± 6.3% at
10
3 M
(P < 0.001 vs. control) (Fig.
1). Addition of the stable ATP analog
ATP
S (10
4 M) led to a
pronounced inhibition of NO production by 50.3 ± 6.5%
(P < 0.001). Neither ATP nor ATP
S
showed an effect by themselves. The inhibitory effect of ATP and
ATP
S was also observed with preincubation of the nucleotides for up
to 8 h before adding LPS/IFN-
(data not shown).
|
Effects of different P2 receptor agonists on nitrite
accumulation in supernatants from cultured rat MCs. The
P2Y2 receptor agonists ATP, UTP, and ATP
S reduced
LPS/IFN-
-induced nitrite accumulation in cultured rat MCs by 36.4 ± 4.3, 29.9 ± 5.8, and 50.3 ± 6.5%, respectively
(P < 0.001 vs. control). No
inhibitory effects could be observed with ATP metabolites such as ADP,
AMP, or adenosine. Furthermore, the P2Y1 agonist 2-MeS-ATP, the
P2X1-P2X6 agonist APCPP, the P2X7 agonist BzATP, and the P2Y6
agonist UDP were without effect (Fig.
2).
|
Expression of P2Y2 receptor mRNA in cultured rat MCs. Homology-based RT-PCR was performed with total RNA from quiescent cultured rat MCs providing PCR products of the expected size of 380 bp visualized on ethidium bromide-stained agarose gels (n = 5), as shown in Fig. 3. Negative controls for the RT and PCR remained negative. In parallel, Northern blot analysis on the same RNA sample has been performed after size fractioning by using a mouse cDNA probe hybridizing to the mRNA to give a signal at 3.0 kb during autoradiographic detection (n = 2) (gift by Dr. D. Julius).
|
Coincubation with ATP reduced the cumulative iNOS mRNA
expression after 24 h of stimulation with LPS/IFN-
in
cultured rat MCs. To further elucidate the inhibitory
mechanism of ATP on LPS/IFN-
-induced NO production, we examined the
effect of P2Y2 receptor activation on iNOS mRNA levels in MCs.
Coincubation with ATP reduced the iNOS transcripts in resting cultured
rat MCs stimulated with LPS/IFN-
in 4 of 4 experiments. The reduced
iNOS mRNA corresponded with the effect on NO production, as assessed by
the nitrite accumulation in the cell culture supernatant (Fig.
4).
|
Coincubation with ATP reduced iNOS protein levels
after 24 h of stimulation with LPS/IFN-
in cultured rat
MCs. To investigate the influence of the reduced iNOS
mRNA levels during P2Y2 receptor activation on iNOS protein
availability for NO production, we coincubated MCs with ATP or ATP
S
during LPS/IFN-
induction. iNOS protein content was reduced in 9 of
11 experiments on Western blot analysis (Fig.
5).
|
Inhibition of iNOS induction by ATP is dependent on
PKC activation. The PKC inhibitors Ro-31-8220 and H-7
have been evaluated to determine whether they alter LPS/IFN-
-induced
nitrite production in the presence or absence of ATP or the PKC
activator PMA. Dose-response experiments have been performed for all
drugs used, and the results have been compared with common dosages
provided in the literature (data not shown). The PKC inhibitors alone
or in combination with LPS/IFN-
did not influence NO production.
Also PMA alone did not lead to an iNOS induction. The inhibitory effect
of ATP (P < 0.001) was completely
reversible by Ro-31-8220 (P < 0.02)
and partially reversible by H-7 (P = 0.05). Furthermore, the decrease in nitrite accumulation provoked by
PMA (P < 0.001) was significantly opposed (P < 0.02) by Ro-31-8220
(Fig. 6).
|
Coincubation of LPS/IFN-
-induced MCs with ATP led to reduced iNOS
protein expression, as has been discussed before. A similar effect on
iNOS enzyme abundance was observed when PMA was used instead of ATP.
The inhibitory effect of ATP and PMA on the expression of iNOS protein
was reversed by adding either the PKC inhibitor Ro-31-8220 or H-7, as
shown in Fig. 7
(n = 3). The addition of Ro-31-8220 or
H-7 without ATP or PMA during the induction period did not affect the
iNOS protein expression (n = 2).
|
| |
DISCUSSION |
|---|
|
|
|---|
Injury of glomerular cells and aggregation of thrombocytes occur in many types of glomerular disease, both in experimental animals and in humans (22). Nucleotides are present in the cytosol of all cell types, as well as in the dense granules of thrombocytes. These molecules are thought to be released into the extracellular space during glomerular injury. The concentration of ATP in the cytosol of most cell types is 2-5 mM. However, in the dense granules of thrombocytes, the ATP level is even higher and reaches the molar range (11). Therefore, the concentration of ATP is very likely in the millimolar to micromolar range in vivo in the vicinity of injured cells and aggregated thrombocytes.
Glomerular MCs are thought to play a critical role in the progression of glomerular disease (42). It has been proposed by several authors that MCs are targets for the effects of extracellular nucleotides. Extracellular ATP induced MC proliferation in cell culture (18, 19, 40). Furthermore, studies in animal models of experimental glomerulonephritis support the concept that extracellular nucleotides are proinflammatory mediators in glomerular disease (36).
To further investigate the possible role of extracellular nucleotides
in the glomerular inflammatory response, we examined whether
extracellular nucleotides may regulate the expression of iNOS,
which is thought to play an important role in the pathogenesis of
glomerulonephritis (12, 21, 30). We found that the nucleotides ATP,
UTP, and ATP
S dose-dependently inhibited nitrite production in
cultured rat MCs during coincubation with LPS/IFN-
, which are known
inducers of iNOS. The reduced nitrite accumulation paralleled the
reduction in iNOS mRNA and iNOS protein, indicating that nucleotides primarily decrease iNOS mRNA levels, which resulted in diminished iNOS
enzyme and NO production.
In additional experiments, we sought to determine the P2 receptors and
signal transduction pathways involved in the inhibitory effect of
extracellular ATP on iNOS induction in cultured MCs. In recent years,
fourteen different P2 receptors (P2X1-P2X7 and P2Y1-P2Y7),
which are stimulated by extracellular nucleotides, have been cloned (3,
10). Although specific antagonists for the different receptor types are
lacking, the agonistic potency of various nucleotides at each P2
receptor has been determined (3, 10). Based on these pharmacological
data, we were able to demonstrate that the inhibitory effect of ATP on
iNOS expression was due to activation of the P2Y2 receptor (previously
designated as P2U receptor) but not activation of any of the other
known P2 receptors. The observed effect was not due to P2X receptor activation, since APCPP, which stimulates P2X1-P2X6 receptors, and
the P2X7 agonist BzATP were without effect. Furthermore, the lacking
effect of 2-MeS-ATP, ADP, and UDP excluded P2Y1, P2Y3, and P2Y6
receptors, respectively. The P2Y4 receptor was excluded since it is
stimulated only by UTP but not ATP. P2Y5 and P2Y7 receptors are ATP
binding molecules, which never proved to be functional receptors (16,
24). Therefore, it is concluded that ATP-mediated inhibition of iNOS
activation is due to activation of P2Y2 receptors, which have been
shown to be stimulated by ATP, UTP, and ATP
S (26). Correspondingly,
we found that MCs expressed mRNA for the P2Y2 receptor using
homology-based RT-PCR and Northern blot analysis.
We excluded effects of ATP degradation products by comparing the ATP
effect with the stable analog, ATP
S, which also inhibited LPS/IFN-
-induced nitrite production in MCs. By contrast, the degradation products of extracellular ATP (ADP, AMP and adenosine) did
not mimic the inhibitory effect of ATP.
P2Y2 receptors belong to the family of G protein-coupled heptahelical
receptors, which have been shown to activate phospholipase C and PKC in
MCs (33, 34, 40). Therefore, we investigated the potential involvement
of PKC during the signal transduction events leading to suppression of
iNOS. We demonstrated that the inhibitory effect of ATP on iNOS protein
expression and nitrite production could be reversed by different PKC
inhibitors, suggesting an involvement of PKCs. The ATP-dependent
decrease of LPS/IFN-
-induced NO production and iNOS expression was
mimicked by coincubation with PMA. This effect was reversible on
addition of the PKC inhibitors. In other cell types, contrasting
effects of PKCs on iNOS expression have been described. In avian
osteoclasts, which also do enhance iNOS expression in response to
inflammatory stimuli, acute administration of PMA led to an increase in
iNOS mRNA, protein, and nitrite (44). In contrast, a number of reports
have been published on either interleukin-1- or LPS-stimulated cell
culture models. There, using, e.g., MCs or macrophage cell lines, acute
treatment with PMA reduced iNOS expression (29, 31). But even
activation of identical PKC isoforms did not have comparable effects on
iNOS expression in different cell lines (9, 29, 31). At present, we
cannot ultimately determine which PKC isoform is involved in
ATP-mediated suppression of iNOS induction in MCs until selective
inhibitors of PKC isoforms are available (17).
Very recently, we found that cultured rat MCs express G protein-coupled
P2Y6 receptors, which are stimulated by extracellular UDP (38).
Although stimulation of the P2Y6 receptor by extracellular UDP results
in signaling events similar to P2Y2 receptor-mediated signaling,
extracellular UDP did not inhibit LPS/IFN-
-induced iNOS activation
as observed with ATP and UTP. Activation of these two different
nucleotide receptors expressed by cultured MCs resulted in different
phenotypic changes, although the primary signal transduction pathways
appear to be similar. The molecular mechanisms involved in these
divergent effects have not yet been determined.
In contrast to our finding in cultured MCs, Denlinger et al. (8)
reported a P2Y1 signaling-mediating iNOS suppression induced by ATP in
macrophages (ex vivo after LPS stimulation and in vitro after
stimulation with LPS/IFN-
). Tonetti et al. (46) described a
stimulation of iNOS activity via not further specified P2Y receptors in
the macrophage cell line RAW 264.7. Greenberg et al. (14) reported that
intratracheal administration of the P2Y1 receptor agonist 2-MeS-ATP
into rats increased iNOS expression in alveolar macrophages obtained by
bronchoalveolar lavage. Concluding from these results, which may be due
to the differing cell types and the stimuli involved, we would like to
stress the importance of a molecular characterization of the assumed
purinergic receptor. Lustig et al. (26) and Tokuyama et al. (45)
provided first evidence for the expression of mRNA for P2Y1 and P2Y2
receptors in the kidney. We extended these observations by showing that quiescent cultured rat MCs express mRNA encoding the functionally postulated P2Y2 receptor.
A cooperative effect of the short-term mediators ATP and NO has been suggested to regulate local blood flow (4). Several investigators have shown that extracellular ATP, e.g., released on shear stress, stimulates NO release from endothelial cells via activation of endothelial NO synthase (2, 4, 15). On the other hand, at subendothelial vascular smooth muscle cells, ATP has been shown to cooperate with norepinephrine in inducing vasoconstriction (4). Since MCs are smooth muscle-like cells of the glomerulus, it is conceivable that the suppressive effect of ATP on iNOS induction serves to preserve the contractile response of glomerular MCs in inflammatory conditions.
Another interrelationship of ATP and NO must be considered in conditions of severe tissue injury. NO generated by the action of iNOS has been shown to cause MC injury in some models of experimental glomerulonephritis (30). Therefore, it is very likely that this detrimental action of NO will result in nucleotide release in this experimental model. Considering the results of the present study, extracellular ATP released from injured tissue may serve to limit further activation of iNOS to prevent excessive tissue damage. As soon as selective P2 receptor blockers are available, these hypotheses on the effects of extracellular ATP and P2Y2 receptor activation on iNOS expression need to be examined in animal models of glomerulonephritis.
| |
ACKNOWLEDGEMENTS |
|---|
We thank C. Staiger for excellent technical assistance.
| |
FOOTNOTES |
|---|
This work was supported by the Deutsche Forschungsgemeinschaft Klinische Forschergruppe "Molekulare Regulationsmechanismen in glomerulären Zellen der Niere."
Present address of M. G. Mohaupt and address for reprint requests: Universitätsspital Bern, Departement Innere Medizin, Nephrologie/Hypertonie, CH-3010 Bern, Switzerland.
Received 11 December 1997; accepted in final form 18 March 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Abboud, H. E.
Resident glomerular cells in glomerular injury: mesangial cells.
Semin. Nephrol.
11:
304-310,
1991[Medline].
2.
Ballermann, B. J.,
and
P. A. Marsden.
Endothelium-derived vasoactive mediators and renal glomerular function.
Clin. Invest. Med.
14:
508-517,
1991[Medline].
3.
Burnstock, G.
Development and perspectives of the purinoceptor concept.
J. Auton. Pharmacol.
16:
295-302,
1996[Medline].
4.
Burnstock, G.
Dual control of local blood flow by purines.
Ann. NY Acad. Sci.
603:
31-44,
1990[Medline].
5.
Burnstock, G,
and
B. F. King.
The numbering of cloned P2 purinoceptors.
Drug. Dev. Res.
38:
67-71,
1996.
6.
Cattell, V.,
T. Cook,
and
S. Moncada.
Glomeruli synthezise NO in experimental nephrotoxic nephritis.
Kidney Int.
38:
1056-1060,
1990[Medline].
7.
Chomczynski, P.,
and
N. Sacchi.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:
156-159,
1987[Medline].
8.
Denlinger, L. C.,
P. L. Fisette,
K. A. Garis,
G. Kwon,
A. Vazquez-Torres,
A. D. Simon,
B. Nguyen,
R. A. Proctor,
P. J. Bertics,
and
J. A. Corbett.
Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium.
J. Biol. Chem.
271:
337-342,
1996
9.
Diaz-Guerra, M. J.,
O. G. Bodelon,
M. Velasco,
R. Whelan,
P. J. Parker,
and
L. Bosca.
Up-regulation of protein kinase C-
promotes the expression of cytokine-inducible nitric oxide synthase in RAW 264.7 cells.
J. Biol. Chem.
271:
32028-32033,
1996
10.
Fredholm, B. B.,
M. P. Abbracchio,
G. Burnstock,
G. R. Dubyak,
T. K. Harden,
K. A. Jacobson,
U. Schwabe,
and
M. Williams.
Towards a revised nomenclature for P1 and P2 receptors.
Trends Pharmacol. Sci.
18:
79-82,
1997[Medline].
11.
Gordon, J. L.
Extracellular ATP: effects, sources and fate.
Biochem. J.
233:
309-319,
1986[Medline].
12.
Goto, S.,
T. Yamamoto,
L. Feng,
E. Yaoita,
S. Hirose,
H. Fujinaka,
K. Kawasaki,
R. Hattori,
Y. Yui,
C. B. Wilson,
M. Arakawa,
and
I. Kihara.
Expression and localization of inducible nitric oxide synthase in anti-Thy-1 glomerulonephritis.
Am. J. Pathol.
147:
1133-1141,
1995[Abstract].
13.
Green, L. C.,
D. A. Wagner,
J. Glogowski,
P. L. Skipper,
J. S. Wishnok,
and
S. R. Tannenbaum.
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.
Anal. Biochem.
126:
131-138,
1982[Medline].
14.
Greenberg, S. S.,
X. Zhao,
J. F. Wang,
L. Hua,
and
J. Ouyang.
cAMP and purinergic P2y receptors upregulate and enhance inducible NO synthase mRNA and protein in vivo.
Am. J. Physiol.
273 (Lung Cell. Mol. Physiol. 17):
L967-L979,
1997
15.
Grierson, J. P.,
and
J. Meldolesi.
Shear stress-induced [Ca2+]i transients and oscillations in mouse fibroblasts are mediated by endogenously released ATP.
J. Biol. Chem.
270:
4451-4456,
1995
16.
Herold, C. L.,
Q. Li,
J. B. Schachter,
T. K. Harden,
and
R. A. Nicholas.
Lack of nucleotide-promoted second messenger signaling responses in 1321N1 cells expressing the proposed P2Y receptor, p2y7.
Biochem. Biophys. Res. Commun.
235:
717-721,
1997[Medline].
17.
Hofmann, J.
The potential for isoenzyme-selective modulation of protein kinase C.
FASEB J.
11:
649-669,
1997[Abstract].
18.
Huwiler, A.,
and
J. Pfeilschifter.
Stimulation by extracellular ATP and UTP of the mitogen-activated protein kinase cascade and proliferation of rat renal mesangial cells.
Br. J. Pharmacol.
113:
1455-1463,
1994[Medline].
19.
Ishikawa, S.,
M. Kawasumi,
I. Kusaka,
N. Komatu,
N. Iwao,
and
T. Saito.
Extracellular ATP promotes cellular growth of glomerular mesangial cells mediated by phospholipase C.
Biochem. Biophys. Res. Commun.
202:
234-240,
1994[Medline].
20.
Ishimura, E.,
R. B. Sterzel,
K. Budde,
and
M. Kashgarian.
Formation of an extracellular matrix by cultured mesangial cells.
Am. J. Pathol.
134:
843-855,
1989[Abstract].
21.
Jansen, A.,
T. Cook,
M. Taylor,
P. Largen,
V. Riveros-Moreno,
S. Moncada,
and
V. Cattell.
Induction of nitric oxide synthase in rat immune complex glomerulonephritis.
Kidney Int.
45:
1215-1219,
1994[Medline].
22.
Johnson, R. J.
The glomerular response to injury: progression or resolution?
Kidney Int.
45:
1769-1782,
1994[Medline].
23.
Kone, B. C.,
and
C. Baylis.
Biosynthesis and homeostatic roles of nitric oxide in the normal kidney.
Am. J. Physiol.
272 (Renal Physiol. 41):
F561-F578,
1997
24.
Li, Q.,
J. B. Schachter,
T. K. Harden,
and
R. A. Nicholas.
The 6H1 orphan receptor, claimed to be the p2y5 receptor, does not mediate nucleotide-promoted second messenger responses.
Biochem. Biophys. Res. Commun.
236:
455-460,
1997[Medline].
25.
Lovett, D. H.,
J. L. Ryan,
and
R. B. Sterzel.
A thymocyte-activating factor derived from glomerular mesangial cells.
J. Immunol.
130:
1796-1801,
1983[Abstract].
26.
Lustig, K. D.,
A. K. Shiau,
A. J. Brake,
and
D. Julius.
Expression cloning of an ATP receptor from mouse neuroblastoma cells.
Proc. Natl. Acad. Sci. USA
90:
5113-5117,
1993
27.
Marsden, P. A.,
and
B. J. Ballermann.
Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism.
J. Exp. Med.
172:
1843-1852,
1990
28.
Mohaupt, M. G.,
J. L. Elzie,
K. Y. Ahn,
W. L. Clapp,
C. S. Wilcox,
and
B. C. Kone.
Differential expression and induction of mRNAs encoding two inducible nitric oxide synthases in rat kidney.
Kidney Int.
46:
653-665,
1994[Medline].
29.
Muhl, H.,
and
J. Pfeilschifter.
Possible role of protein kinase C-
isoenzyme in inhibition of interleukin-1 induction of nitric oxide synthase in rat mesangial cells.
Biochem. J.
303:
607-612,
1994.
30.
Narita, I.,
W. A. Border,
M. Ketteler,
and
N. A. Noble.
Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis.
Lab. Invest.
72:
17-24,
1995[Medline].
31.
Paul, A.,
K. Doherty,
and
R. Plevin.
Differential regulation by protein kinase C isoforms of nitric oxide synthase induction in RAW 264.7 macrophages and rat aortic smooth muscle cells.
Br. J. Pharmacol.
120:
940-946,
1997[Medline].
32.
Pavenstädt, H.,
J. Gloy,
J. Leipziger,
B. Klär,
J. Pfeilschifter,
P. Schollmeyer,
and
R. Greger.
Effects of extracellular ATP on contraction, cytosolic calcium activity, membrane voltage and ion currents of rat mesangial cells in primary culture.
Br. J. Pharmacol.
109:
953-959,
1993[Medline].
33.
Pfeilschifter, J.
Comparison of extracellular ATP and UTP signalling in rat renal mesangial cells.
Biochem. J.
272:
469-472,
1990[Medline].
34.
Pfeilschifter, J.,
and
A. Huwiler.
Regulatory functions of protein kinase C isoenzymes in purinoceptor signalling in mesangial cells.
J. Auton. Pharmacol.
16:
315-318,
1996[Medline].
35.
Pfeilschifter, J.,
and
H. Schwarzenbach.
Interleukin 1 and tumor necrosis factor stimulate cGMP formation in rat renal mesangial cells.
FEBS Lett.
273:
185-187,
1990[Medline].
36.
Poelstra, K.,
E. R. Heynen,
J. F. Baller,
M. J. Hardonk,
and
W. W. Bakker.
Modulation of anti-Thy1 nephritis in the rat by adenine nucleotides. Evidence for an anti-inflammatory role for nucleotidases.
Lab. Invest.
66:
555-563,
1992[Medline].
37.
Schulze-Lohoff, E.,
M. Bitzer,
A. Ogilvie,
and
R. B. Sterzel.
P2U purinergic receptor activation mediates inhibition of cAMP accumulation in cultured renal mesangial cells.
Renal Physiol. Biochem.
18:
219-230,
1995.[Medline]
38.
Schulze-Lohoff, E.,
C. Hugo,
S. Rost,
K. Chang,
Y. Takuwa,
A. Ogilvie,
and
R. B. Sterzel.
UDP increases intracellular calcium, c-fos expression and DNA synthesis in mesangial cells via specific UDP receptors (Abstract).
J. Am. Soc. Nephrol.
8:
A407,
1997.
39.
Schulze-Lohoff, E.,
S. Schagerl,
A. Ogilvie,
and
R. B. Sterzel.
Extracellular ATP augments mesangial cell growth induced by multiple growth factors.
Nephrol. Dial. Transplant.
10:
2027-2034,
1995
40.
Schulze-Lohoff, E.,
S. Zanner,
A. Ogilvie,
and
R. B. Sterzel.
Extracellular ATP stimulates proliferation of cultured mesangial cells via P2-purinergic receptors.
Am. J. Physiol.
263 (Renal Fluid Electrolyte Physiol. 32):
F374-F383,
1992
41.
Shultz, P. J.,
S. L. Archer,
and
M. E. Rosenberg.
Inducible nitric oxide synthase mRNA and activity in glomerular mesangial cells.
Kidney Int.
46:
683-689,
1994[Medline].
42.
Sterzel, R. B.,
E. Schulze-Lohoff,
and
M. Marx.
Cytokines and mesangial cells.
Kidney Int.
43:
S26-S31,
1993.
43.
Stuer, D. J.,
and
M. A. Marletta.
Mammalian nitrite biosynthesis: mouse macrophage produce nitrate and nitrite in response to Escherichia coli lipopolysaccharide.
Proc. Natl. Acad. Sci. USA
82:
7738-7742,
1985
44.
Sunyer, T.,
L. Rothe,
D. Kirsch,
X. Jiang,
F. Anderson,
P. Osdoby,
and
P. Collin-Osdoby.
Ca2+ or phorbol ester but not inflammatory stimuli elevate inducible nitric oxide synthase messenger ribonucleic acid and nitric oxide (NO) release in avian osteoclasts: autocrine NO mediates Ca2+-inhibited bone resorption.
Endocrinology
138:
2148-2162,
1997
45.
Tokuyama, Y.,
M. Hara,
E. M. C. Jones,
Z. Fan,
and
G. I. Bell.
Cloning of rat and mouse P2y purinoceptors.
Biochem. Biophys. Res. Commun.
211:
211-218,
1995[Medline].
46.
Tonetti, M.,
L. Sturla,
T. Bistolfi,
U. Benatti,
and
A. De Flora.
Extracellular ATP potentiates nitric oxide synthase expression induced by lipopolysaccharide in RAW 264.7 murine macrophages.
Biochem. Biophys. Res. Commun.
203:
430-435,
1994[Medline].
47.
Weinberg, J. B.,
D. L. Granger,
D. S. Pisetsky,
M. F. Seldin,
M. A. Misukonis,
S. N. Mason,
A. M. Pippen,
P. Ruiz,
E. R. Wood,
and
G. S. Gilkeson.
The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthits by orally administered NG-monomethyl-L-arginine.
J. Exp. Med.
179:
651-660,
1994
48.
Xie, Q. W.,
and
C. Nathan.
Promotor of the mouse gene encoding calcium independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide.
Trans. Assoc. Am. Phys.
106:
1-12,
1993[Medline].
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |